Effects of Telmisartan and Candesartan on the Metabolism of Lipids and Glucose in Kidney Transplant Patients: A Prospective, Randomized Crossover Study

BACKGROUND: The risk of cardiovascular events remains after kidney transplantation (KT). Abnormal glucose metabolism and hyperlipidemia contribute partly to this risk. Among angiotensin II type-1 receptor blockers, telmisartan alone has been shown to ameliorate these effects on glucose and lipid met...

Descripción completa

Detalles Bibliográficos
Autores principales: Miura, Yoshifumi, Noguchi, Hiroshi, Okabe, Yasuhiro, Masutani, Kosuke, Tokunaga, Shoji, Nakamura, Masafumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Kidney Transplantation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415969/
https://www.ncbi.nlm.nih.gov/pubmed/30882027
http://dx.doi.org/10.1097/TXD.0000000000000861

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6415969/
https://www.ncbi.nlm.nih.gov/pubmed/30882027
http://dx.doi.org/10.1097/TXD.0000000000000861

Ejemplares similares